March 04, 2026

Refining Vancomycin Use in Early CDI

A modified dosing approach could reshape recurrence prevention strategies.

Conexiant

February 19, 2026

Proton Pump Inhibitors and Cancer Risk

Investigators evaluate cancer risk tied to extended acid suppression therapy.

Conexiant

February 13, 2026

Conjugative CRISPR System Cuts Resistance

Mobile gene drive-like platform spreads between bacteria and reduces ampicillin resistance by up to 5 logs while enabling cassette reversal

Conexiant

January 27, 2026

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.

Conexiant

February 12, 2026

15x Spike: What Louisville Found

Scientists trace a PFAS surge 400 miles upstream.

KFF Health News

June 17, 2025

FMT as First-Line CDI Treatment?

New randomized trial shows fecal microbiota transplantation may reduce antibiotic dependence in first-episode infections

Conexiant

August 12, 2025

FDA Approves First Therapy for Non-cystic Fibrosis Bronchiectasis

Brensocatib (Brinsupri) will offer a new treatment option for patients 12 years and older.

Conexiant

September 09, 2025

Dietary Nitrate Lowers Blood Pressure in Older Adults, Study

Researchers show nitrate-rich beetroot reshapes the oral microbiome.

Conexiant

November 10, 2025

Gastric microbiome shifts track H pylori virulence

Pathogenic bacterial genotypes correlate with distinct microbial communities; overall α-diversity is unchanged, but virulent strains show greater diversity within subgroups as atrophy progresses

Conexiant

August 25, 2021

A Worm's-Eye View

A new approach – based on MALD-MSI and micro-CT – aims to bring unprecedented levels of detail to the study of host-microbe interactions, starting with the earthworm

The Analytical Scientist